|
2025
|
P/S
|
Pharmaceutical and biological preparations and medicinal infusions for prevention and treatment o... |
|
|
P/S
|
Pharmaceutical and biological preparations and medicinal
infusions for prevention and treatment ... |
|
|
P/S
|
Antiviral pharmaceuticals; immunotherapy pharmaceuticals; antiviral pharmaceuticals for use in th... |
|
|
P/S
|
Antiviral pharmaceuticals; immunotherapy pharmaceuticals;
antiviral pharmaceuticals for use in t... |
|
2024
|
Invention
|
Modulators of coronavirus 3c-like protease and uses thereof. The present disclosure provides modu... |
|
|
Invention
|
Cmv-based human papillomavirus vaccines. The disclosure relates to human papillomavirus (HPV) ant... |
|
|
Invention
|
Cmv-based human papillomavirus vaccines.
The disclosure relates to human papillomavirus (HPV) an... |
|
|
P/S
|
Antiviral pharmaceuticals; immunotherapy pharmaceuticals for the treatment of cancer, tumors, and... |
|
|
Invention
|
Broadly neutralizing antibodies against rsv and mpv paramyxoviruses. The instant disclosure provi... |
|
|
Invention
|
Antibodies against staphylococcus antigens and methods of using the same. StaphylococcusStaphyloc... |
|
|
Invention
|
Sulfoximine based stt3a/b modulators for the treatment of disease. The disclosure provides sulfox... |
|
|
Invention
|
Enpp1 modulators and uses thereof.
The disclosure provides enantiomeric quinoline and aza-quinaz... |
|
|
Invention
|
Antibodies that bind to multiple sarbecoviruses. The instant disclosure provides antibodies and a... |
|
|
Invention
|
Coronavirus compositions and uses thereof. Provided herein are engineered coronavirus polypeptide... |
|
2023
|
Invention
|
Engineered anti-sars-cov-2 antibodies and methods of using the same. The instant disclosure provi... |
|
|
Invention
|
Engineered anti-sars-cov-2 antibodies and uses thereof. The instant disclosure provides antibodie... |
|
|
Invention
|
Using sparse electronic health records for predicting health outcome. EHR data records often incl... |
|
|
Invention
|
Broadly neutralizing antibodies against rsv and mpv paramyxoviruses |
|
|
Invention
|
Broadly neutralizing antibodies against influenza neuraminidase. The instant disclosure provides ... |
|
|
Invention
|
Combination immunotherapy for influenza. in vivo in vivo half-life of the antibody or antigen-bin... |
|
|
Invention
|
Broadly neutralizing antibodies against influenza neuraminidase |
|
|
Invention
|
Fc-engineered hepatitis b virus neutralizing antibodies and uses thereof. e.g.e.g., Fc polypeptid... |
|
|
Invention
|
Inhibitors of deoxyhypusine synthase for the treatment and prevention of respiratory virus infect... |
|
|
Invention
|
Inhibitor of deoxyhypusine hydroxylase for the treatment and prevention of respiratory virus infe... |
|
|
Invention
|
Compositions and methods for treating hepatitis d virus (hdv) infection and associated diseases. ... |
|
|
Invention
|
Compositions and methods for treating hepatitis b virus (hbv) infection and hbv-associated diseas... |
|
|
Invention
|
Naphthyridine based enpp1 modulators and uses thereof. The disclosure provides naphthyridines bas... |
|
|
Invention
|
High dose antibody therapies for sars-cov-2 infection. The instant disclosure provides methods of... |
|
2022
|
Invention
|
Treatment of respiratory virus infection by modulation of the n-glycosylation pathway.
The prese... |
|
|
Invention
|
Heterocycle derivatives for the treatment of disease. The disclosure provides heterocycle derivat... |
|
|
Invention
|
Enpp1 modulators and uses thereof.
The disclosure provides compositions and methods of quinoline... |
|
|
Invention
|
Virological and molecular surrogates of response to sars-cov-2 neutralizing antibody sotrovimab. ... |
|
|
Invention
|
Enpp1 modulators and uses thereof. The disclosure provides enantiomeric quinoline and aza-quinazo... |
|
|
Invention
|
Small molecule inducers of autophagy. The present disclosure provides compounds or salts of Formu... |
|
|
Invention
|
Broadly neutralizing antibody combination therapies for sars-cov-2 infection. The present disclos... |
|
|
Invention
|
Antibody therapies for sars-cov-2 infection in pediatric subjects.
The instant disclosure provid... |
|
|
Invention
|
Methods for producing cmv vectors.
The present disclosure provides methods for producing cytomeg... |
|
|
Invention
|
Recombinant hcmv vectors and uses thereof.
The disclosure relates to human cytomegalovirus (HCMV... |
|
|
Invention
|
Tuberculosis vaccines.
The disclosure relates to tuberculosis antigens and vectors for deliverin... |
|
|
Invention
|
Tuberculosis vaccines. The disclosure relates to tuberculosis antigens and vectors for delivering... |
|
|
Invention
|
Machine learning for predicting mutational drivers and likely onset of future pandemics.
Methods... |
|
|
Invention
|
Combination of a tlr8 modulating compound and anti-hbv sirna therapeutics.
The present disclosur... |
|
|
P/S
|
Pharmaceuticals; pharmaceuticals for use in the treatment of
infectious diseases and disorders a... |
|
|
P/S
|
Pharmaceutical anti-viral agents; pharmaceutical preparations for use in the treatment of infecti... |
|
|
Invention
|
Non-viral dna vectors expressing anti-coronavirus antibodies and uses thereof.
The application d... |
|
|
Invention
|
Compositions and methods for treating hepatitis b virus infection.
The present disclosure relate... |
|
2021
|
Invention
|
Antibodies and methods for treatment of influenza a infection.
The present disclosure provides a... |
|
|
P/S
|
Research and development in the pharmaceutical and
biotechnology fields; development of pharmace... |
|
|
Invention
|
Antibodies against influenza a viruses.
The instant disclosure provides antibodies and antigen-b... |
|
|
Invention
|
Anti-influenza antibodies and combinations thereof.
The present disclosure relates, in part, to ... |
|
|
Invention
|
Broadly neutralizing antibodies against influenza neuraminidase.
The instant disclosure provides... |
|
|
Invention
|
Predictive universal signatures for multiple disease indications.
Universal signatures represent... |
|
|
Invention
|
Engineered hepatitis b virus neutralizing antibodies and uses thereof.
The present disclosure re... |
|
|
Invention
|
Antibodies against sars-cov-2 and methods of using the same.
The instant disclosure provides ant... |
|
|
P/S
|
Pharmaceuticals. Medical research and information services. |
|
2020
|
P/S
|
Pharmaceuticals, namely, proteins, antibodies, and large molecules for use in the treatment of vi... |
|
|
Invention
|
Antibodies binding to plasmodium circumsporozoite protein and uses thereof.
The present inventio... |
|
2019
|
P/S
|
Research and development in the pharmaceutical and biotechnology fields; development of pharmaceu... |
